BR112012000596A2 - processo e composições farmacêuticas para o tratamento de hiperglicemia pós-prandial de diabetes tipo ii por via transmucosa bucal - Google Patents

processo e composições farmacêuticas para o tratamento de hiperglicemia pós-prandial de diabetes tipo ii por via transmucosa bucal

Info

Publication number
BR112012000596A2
BR112012000596A2 BR112012000596A BR112012000596A BR112012000596A2 BR 112012000596 A2 BR112012000596 A2 BR 112012000596A2 BR 112012000596 A BR112012000596 A BR 112012000596A BR 112012000596 A BR112012000596 A BR 112012000596A BR 112012000596 A2 BR112012000596 A2 BR 112012000596A2
Authority
BR
Brazil
Prior art keywords
diabetes
treatment
type
pharmaceutical compositions
postprandial hyperglycemia
Prior art date
Application number
BR112012000596A
Other languages
English (en)
Inventor
Jean-Pierre Dumonteix
Marc Maury
Philippe Perovitch
Original Assignee
Jean-Pierre Dumonteix
Marc Maury
Philippe Perovitch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jean-Pierre Dumonteix, Marc Maury, Philippe Perovitch filed Critical Jean-Pierre Dumonteix
Publication of BR112012000596A2 publication Critical patent/BR112012000596A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
BR112012000596A 2009-07-10 2010-07-07 processo e composições farmacêuticas para o tratamento de hiperglicemia pós-prandial de diabetes tipo ii por via transmucosa bucal BR112012000596A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0954819A FR2947729B1 (fr) 2009-07-10 2009-07-10 Composition pharmaceutique pour le traitement du diabete de type ii par voie trans-muqueuse buccale
PCT/FR2010/051426 WO2011004117A1 (fr) 2009-07-10 2010-07-07 Procédé et compositions pharmaceutiques pour le traitement de l'hyper glycémie post-prandiale du diabète de type ii par voie trans-muqueuse buccale

Publications (1)

Publication Number Publication Date
BR112012000596A2 true BR112012000596A2 (pt) 2016-02-10

Family

ID=41571558

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012000596A BR112012000596A2 (pt) 2009-07-10 2010-07-07 processo e composições farmacêuticas para o tratamento de hiperglicemia pós-prandial de diabetes tipo ii por via transmucosa bucal

Country Status (10)

Country Link
US (1) US9161910B2 (pt)
EP (1) EP2451436A1 (pt)
JP (1) JP2012532852A (pt)
CN (1) CN102481254A (pt)
BR (1) BR112012000596A2 (pt)
FR (1) FR2947729B1 (pt)
IN (1) IN2012DN00977A (pt)
MX (1) MX337606B (pt)
RU (1) RU2543635C2 (pt)
WO (1) WO2011004117A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2940116B1 (fr) * 2008-12-22 2012-07-06 Philippe Perovitch Formulation pour l'administration d'hypolipemiant par voie trans-muqueuse buccale
FR3000896B1 (fr) * 2013-01-14 2016-08-26 Philippe Perovitch Forme galenique pour l'administration de principe(s) actif(s) permettant l'induction acceleree du sommeil et/ou le traitement des troubles du sommeil
FR3031668A1 (fr) 2015-01-20 2016-07-22 Philippe Perovitch Dispositif d'administration d'un principe actif par voie per-muqueuse buccale.
FR3053244A1 (fr) 2016-07-01 2018-01-05 Philippe Perovitch Dispositif d'administration d'au moins un principe actif par voie per-muqueuse buccale.
CN107669683B (zh) * 2017-09-30 2020-07-03 杭州华东医药集团新药研究院有限公司 含有西格列汀与二甲双胍的药物组合物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2071779C1 (ru) * 1993-05-12 1997-01-20 Хабаровский химико-фармацевтический завод Способ получения пантокрина для инъекций
US20030095925A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
US6451286B1 (en) * 1998-12-21 2002-09-17 Generex Pharmaceuticals Incorporated Pharmaceutical compositions for buccal and pulmonary administration comprising an alkali metal alkyl sulfate and at least three micelle-forming compounds
US20030087820A1 (en) * 1999-01-14 2003-05-08 Young Andrew A. Novel exendin agonist formulations and methods of administration thereof
US20030235595A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Oil-containing, orally administrable pharmaceutical composition for improved delivery of a therapeutic agent
US7411089B2 (en) * 2002-04-15 2008-08-12 Ajinomoto Co., Inc. Nateglinide crystals
SE528866C2 (sv) * 2005-07-01 2007-02-27 Volvo Lastvagnar Ab Anordning för att kontrollera höjden hos en last eller lastbärare bakom förarhytten hos en lastbil
CN101263107A (zh) * 2005-08-30 2008-09-10 艾博特公司 作为二肽基肽酶-iv(dpp-iv)抑制剂的药物组合物
DE102006027790A1 (de) * 2006-06-16 2007-12-20 Lts Lohmann Therapie-Systeme Ag Typ-2-Diabetes Kombinations-Wafer
CA2659245A1 (en) * 2006-07-28 2008-01-31 Novadel Pharma Inc. Anti-migraine oral spray formulations and methods
FR2906140B1 (fr) * 2006-09-22 2008-12-05 Philippe Perovitch Forme galenique pour l'administration par voie trans-muqueuse de principes actifs

Also Published As

Publication number Publication date
US9161910B2 (en) 2015-10-20
FR2947729A1 (fr) 2011-01-14
IN2012DN00977A (pt) 2015-04-10
EP2451436A1 (fr) 2012-05-16
US20120190618A1 (en) 2012-07-26
MX337606B (es) 2016-03-10
WO2011004117A1 (fr) 2011-01-13
FR2947729B1 (fr) 2012-01-20
RU2012104639A (ru) 2013-08-20
CN102481254A (zh) 2012-05-30
RU2543635C2 (ru) 2015-03-10
MX2012000466A (es) 2012-04-19
JP2012532852A (ja) 2012-12-20

Similar Documents

Publication Publication Date Title
SMT201700095B (is) Composizioni farmaceutiche per inalazione
BRPI0920941A2 (pt) composições para tratamento bucal com sílica fundida.
BR112012000296A2 (pt) composição e método para produção de um propante cerâmico ultraleve.
DK3097925T3 (da) Farmaceutisk sammensætning
BRPI0907598A2 (pt) Processo para o preparo de formulações de dabigatrana administradas por via oral
BRPI1004940A2 (pt) composição farmacêutica
BR112012012108A2 (pt) composição farmacêutica compreendendo propofol
BRPI0913785A2 (pt) adaptador bucal para aplicação de tratamento bucal
BRPI1012116A2 (pt) composição farmacêutica para o tratamento de doenças cardíacas
DK2451435T4 (da) Natriumthiosulfat-indeholdende farmaceutiske sammensætninger
BRPI1015939A2 (pt) composição farmacêutica
BRPI1007161A2 (pt) composição farmacêutica oral, e processo para preparar uma composição
BRPI0910545A2 (pt) processo contínuo para fazer composições farmacêuticas
DK2285413T3 (da) Farmaceutisk sammensætning
BRPI0908859A2 (pt) composição farmacêutica estabilizada de líquído único contedo docetaxel
BRPI0907950A2 (pt) Tratamento de hiperglicemia com 25-hidroxivitamina d3
BRPI1007484A2 (pt) composição farmacêutica para administração oral
BRPI1007474A2 (pt) formulação para administração por via transmucosa oral de moléculas antálgicas e/ou antiespasmódicos.
BRPI0921313A2 (pt) composição farmaucêutica
BRPI1010707A2 (pt) composição farmacêutica, processo para o preparo da mesma, processo para o preparo de uma formulação injetável e formulação injetável
BRPI0913610A2 (pt) métodos e composições para tratamento bucal
BR112012006602A2 (pt) processo para a purificação de eritropoetina humana recombinante (epo), epo assim purificada e composições farmacêutica compreendendo a mesma
BR112012000596A2 (pt) processo e composições farmacêuticas para o tratamento de hiperglicemia pós-prandial de diabetes tipo ii por via transmucosa bucal
BR112012003149A2 (pt) composição farmacêutica
BRPI0916486A2 (pt) composição para tratamento bucal

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2521 DE 30-04-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B350 Update of information on the portal [chapter 15.35 patent gazette]